PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
XBI vs. ARKK
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Correlation

The correlation between XBI and ARKK is 0.71, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.


-0.50.00.51.00.7

Performance

XBI vs. ARKK - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in SPDR S&P Biotech ETF (XBI) and ARK Innovation ETF (ARKK). The values are adjusted to include any dividend payments, if applicable.

-10.00%0.00%10.00%20.00%30.00%40.00%50.00%JulyAugustSeptemberOctoberNovemberDecember
0.19%
34.13%
XBI
ARKK

Key characteristics

Sharpe Ratio

XBI:

0.26

ARKK:

0.26

Sortino Ratio

XBI:

0.54

ARKK:

0.61

Omega Ratio

XBI:

1.06

ARKK:

1.07

Calmar Ratio

XBI:

0.13

ARKK:

0.13

Martin Ratio

XBI:

0.83

ARKK:

0.65

Ulcer Index

XBI:

8.11%

ARKK:

14.40%

Daily Std Dev

XBI:

26.35%

ARKK:

35.96%

Max Drawdown

XBI:

-63.89%

ARKK:

-80.91%

Current Drawdown

XBI:

-48.22%

ARKK:

-62.23%

Returns By Period

In the year-to-date period, XBI achieves a 0.86% return, which is significantly lower than ARKK's 11.08% return. Over the past 10 years, XBI has underperformed ARKK with an annualized return of 3.74%, while ARKK has yielded a comparatively higher 12.30% annualized return.


XBI

YTD

0.86%

1M

-2.21%

6M

0.40%

1Y

4.11%

5Y*

-1.37%

10Y*

3.74%

ARKK

YTD

11.08%

1M

4.02%

6M

34.12%

1Y

14.04%

5Y*

3.43%

10Y*

12.30%

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


XBI vs. ARKK - Expense Ratio Comparison

XBI has a 0.35% expense ratio, which is lower than ARKK's 0.75% expense ratio.


ARKK
ARK Innovation ETF
Expense ratio chart for ARKK: current value at 0.75% compared with the broader market ranging from 0.00% to 2.12%.0.50%1.00%1.50%2.00%0.75%
Expense ratio chart for XBI: current value at 0.35% compared with the broader market ranging from 0.00% to 2.12%.0.50%1.00%1.50%2.00%0.35%

Risk-Adjusted Performance

XBI vs. ARKK - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for SPDR S&P Biotech ETF (XBI) and ARK Innovation ETF (ARKK). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for XBI, currently valued at 0.16, compared to the broader market0.002.004.000.160.26
The chart of Sortino ratio for XBI, currently valued at 0.40, compared to the broader market-2.000.002.004.006.008.0010.000.400.61
The chart of Omega ratio for XBI, currently valued at 1.05, compared to the broader market0.501.001.502.002.503.001.051.07
The chart of Calmar ratio for XBI, currently valued at 0.08, compared to the broader market0.005.0010.0015.000.080.13
The chart of Martin ratio for XBI, currently valued at 0.50, compared to the broader market0.0020.0040.0060.0080.00100.000.500.65
XBI
ARKK

The current XBI Sharpe Ratio is 0.26, which is comparable to the ARKK Sharpe Ratio of 0.26. The chart below compares the historical Sharpe Ratios of XBI and ARKK, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio0.000.501.001.502.00JulyAugustSeptemberOctoberNovemberDecember
0.16
0.26
XBI
ARKK

Dividends

XBI vs. ARKK - Dividend Comparison

XBI's dividend yield for the trailing twelve months is around 0.14%, while ARKK has not paid dividends to shareholders.


TTM20232022202120202019201820172016201520142013
XBI
SPDR S&P Biotech ETF
0.14%0.02%0.00%0.04%0.20%0.00%0.28%0.24%0.26%0.61%1.07%0.17%
ARKK
ARK Innovation ETF
0.00%0.00%0.00%0.83%1.31%0.38%3.14%1.32%0.00%2.27%0.00%0.00%

Drawdowns

XBI vs. ARKK - Drawdown Comparison

The maximum XBI drawdown since its inception was -63.89%, smaller than the maximum ARKK drawdown of -80.91%. Use the drawdown chart below to compare losses from any high point for XBI and ARKK. For additional features, visit the drawdowns tool.


-75.00%-70.00%-65.00%-60.00%-55.00%-50.00%-45.00%-40.00%JulyAugustSeptemberOctoberNovemberDecember
-48.22%
-62.23%
XBI
ARKK

Volatility

XBI vs. ARKK - Volatility Comparison

The current volatility for SPDR S&P Biotech ETF (XBI) is 7.78%, while ARK Innovation ETF (ARKK) has a volatility of 11.49%. This indicates that XBI experiences smaller price fluctuations and is considered to be less risky than ARKK based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


4.00%6.00%8.00%10.00%12.00%14.00%JulyAugustSeptemberOctoberNovemberDecember
7.78%
11.49%
XBI
ARKK
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2024 PortfoliosLab